Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

416 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.
Hawa MI, Kolb H, Schloot N, Beyan H, Paschou SA, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Beck-Neilsen H, Tuomilehto J, Sarti C, Thivolet C, Hadden D, Hunter S, Schernthaner G, Scherbaum WA, Williams R, Brophy S, Pozzilli P, Leslie RD; Action LADA consortium. Hawa MI, et al. Among authors: scherbaum wa. Diabetes Care. 2013 Apr;36(4):908-13. doi: 10.2337/dc12-0931. Epub 2012 Dec 17. Diabetes Care. 2013. PMID: 23248199 Free PMC article.
Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11.
Schloot NC, Pham MN, Hawa MI, Pozzilli P, Scherbaum WA, Schott M, Kolb H, Hunter S, Schernthaner G, Thivolet C, Seissler J, Leslie RD; Action LADA Group. Schloot NC, et al. Among authors: scherbaum wa. Diabetes Care. 2016 Nov;39(11):1932-1939. doi: 10.2337/dc16-0293. Epub 2016 Aug 29. Diabetes Care. 2016. PMID: 27573939
Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes.
Gu Y, Jia X, Vartak T, Miao D, Dong F, Jerram ST, Rewers M, Ferrara A, Lawrence JM, Yu L, Leslie RD; Action LADA consortium and the Diabetes in Young Adults (DiYA) Study Group. Gu Y, et al. Diabetologia. 2021 Sep;64(9):2052-2060. doi: 10.1007/s00125-021-05492-6. Epub 2021 Jul 16. Diabetologia. 2021. PMID: 34272582 Free PMC article.
Diabetes classification: grey zones, sound and smoke: Action LADA 1.
Leslie RD, Kolb H, Schloot NC, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Sarti C, Thivolet C, Hadden D, Hunter S, Schernthaner G, Scherbaum W, Williams R, Pozzilli P. Leslie RD, et al. Diabetes Metab Res Rev. 2008 Oct;24(7):511-9. doi: 10.1002/dmrr.877. Diabetes Metab Res Rev. 2008. PMID: 18615859 Review.
Autoimmune diagnostics in diabetes mellitus.
Seissler J, Scherbaum WA. Seissler J, et al. Among authors: scherbaum wa. Clin Chem Lab Med. 2006;44(2):133-7. doi: 10.1515/CCLM.2006.025. Clin Chem Lab Med. 2006. PMID: 16475896 Free article. Review.
Distinct monocyte gene-expression profiles in autoimmune diabetes.
Padmos RC, Schloot NC, Beyan H, Ruwhof C, Staal FJ, de Ridder D, Aanstoot HJ, Lam-Tse WK, de Wit H, de Herder C, Drexhage RC, Menart B, Leslie RD, Drexhage HA; LADA Consortium. Padmos RC, et al. Diabetes. 2008 Oct;57(10):2768-73. doi: 10.2337/db08-0496. Epub 2008 Jul 3. Diabetes. 2008. PMID: 18599519 Free PMC article.
Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4.
Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum WA, Seissler J, Kolb H, Hunter S, Leslie RD, Schloot NC; Action LADA Study Group. Pham MN, et al. Among authors: scherbaum wa. Diabetologia. 2011 Jul;54(7):1630-8. doi: 10.1007/s00125-011-2088-6. Epub 2011 Feb 24. Diabetologia. 2011. PMID: 21347621
416 results